Mei Ri Jing Ji Xin Wen·2025-11-28 10:52Core Viewpoint - The company Zhongguancun announced plans to secure a financing credit of up to 10 million RMB to supplement its working capital, backed by collateral and guarantees from the company itself [1] Group 1: Financing and Guarantees - Zhongguancun's subsidiary Zhongshi Tongda intends to apply for a financing credit from Nanjing Bank, with a limit not exceeding 10 million RMB and a term of no more than one year [1] - The company will provide joint liability guarantees for the financing application and will use certain real estate assets as collateral, including parts of a building and land use rights located in Haidian District, Beijing [1] - The assessed value of the collateral, as per the evaluation report dated July 14, 2025, is approximately 26.13 million RMB [1] Group 2: Revenue Composition - For the first half of 2025, Zhongguancun's revenue composition is as follows: Biopharmaceuticals account for 80.15%, Concrete for 13.22%, Elderly Health for 4.12%, and Others for 2.51% [1] Group 3: Market Valuation - As of the report, Zhongguancun's market capitalization stands at 3.9 billion RMB [1]